P2Y12 & Microglial Self-Renewal

P2Y12 is a G-protein-coupled receptor known for its role in platelet activation. However, its role in the CNS and involvement in microglial activation and renewal is less well understood. Discover the latest research on P2Y12 and microglial self-renewal here.

September 6, 2021

Neural Injury and Repair in a Novel Neonatal Mouse Model of Listeria Monocytogenes Meningoencephalitis.

Journal of Neuropathology and Experimental Neurology
Jana SeeleRoland Nau
September 3, 2021

In vitro model of traumatic brain injury to screen neuro-regenerative biomaterials.

Materials Science & Engineering. C, Materials for Biological Applications
Raja Haseeb BasitDivya Maitreyi Chari
August 30, 2021

Microglia as the Critical Regulators of Neuroprotection and Functional Recovery in Cerebral Ischemia.

Cellular and Molecular Neurobiology
Bhakta Prasad Gaire
August 27, 2021
Open Access

Repair Mechanisms of the Neurovascular Unit after Ischemic Stroke with a Focus on VEGF.

International Journal of Molecular Sciences
Sunhong MoonYoon Kyung Choi
August 24, 2021
Open Access

TREM2 regulates purinergic receptor-mediated calcium signaling and motility in human iPSC-derived microglia

BioRxiv : the Preprint Server for Biology
A. JairamanMichael D Cahalan
August 24, 2021

Effects of Gynostemma pentaphyllum on spinal cord motor neurons and microglial cells in vitro.

Acta histochemica
Gerburg KeilhoffBenjamin Lucas
August 23, 2021
Open Access

New Insights Into the Roles of Microglial Regulation in Brain Plasticity-Dependent Stroke Recovery.

Frontiers in Cellular Neuroscience
Fang YuZongjian Liu
August 21, 2021

Retinal Ganglion Cell Axon Regeneration Requires Complement and Myeloid Cell Activity within the Optic Nerve.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Sheri L PetersonLarry I Benowitz
August 13, 2021

A neurovascular-unit-on-a-chip for the evaluation of the restorative potential of stem cell therapies for ischaemic stroke.

Nature Biomedical Engineering
Zhonglin LyuWonjae Lee
August 6, 2021
Open Access

Oligodendrocytes and Microglia: Key Players in Myelin Development, Damage and Repair.

Ilias Kalafatakis, Domna Karagogeos
August 4, 2021
Open Access

Retinoic acid treatment recruits macrophages and increases axonal regeneration after optic nerve injury in the frog Rana pipiens

BioRxiv : the Preprint Server for Biology
V. De La Rosa-ReyesRosa E Blanco
July 17, 2021
Open Access

Fractalkine signaling regulates oligodendroglial cell genesis from SVZ precursor cells.

Stem Cell Reports
Adrianne E S WatsonAnastassia Voronova
July 17, 2021
Open Access

Antinociceptive Effect of Magnolol in a Neuropathic Pain Model of Mouse.

Journal of Pain Research
Xiao ZhangZhenfang Liu

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved